← Every firm
Golden State Medical Supply Inc. FDA Recalls
27 recalls on file across drugs, 1 of them Class I and 14 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, Class IIAug 21, 2026Failed Dissolution Specifications. Notification from the man |
| Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, Not Yet ClassifiedAug 21, 2026undeclared ingredients including but not limited to mustard |
| Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-Class IIAug 7, 2026CGMP deviations: tablets with black specks. |
| GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban PhClass IIMay 29, 2026Failed Dissolution Specifications: During 12-month long-term |
| Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, IncoClass IIIApr 27, 2026Cross contamination with other products: API contaminated wi |
| Primidone Tablets, USP, 250 mg, 100-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, InClass IIIApr 27, 2026Cross contamination with other products: API contaminated wi |
| Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-1Class IINov 26, 2025Presence of Foreign Tablets/Capsules |
| NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban PharmaceuClass IIOct 20, 2025Failed Dissolution Specifications |
| PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-3Class IIMar 5, 2025Failed Dissolution Specifications |
| Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, NDC 60429-165-30; b) 90 capsules bottleClass IIMay 13, 2024CGMP Deviations: Presence of Nitrosamine Drug Substance Rela |
| Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: AClass IIFeb 14, 2024CGMP Deviations:Suspected potential presence of Burkholderia |
| Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPClass IIJan 12, 2024Failed Dissolution Specifications |
| PAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30; b) 90-count bottle NDC 60429-734-90; Class IINov 10, 2023Failed Impurities/Degradation Specifications-Manufacturer Ap |
| PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30; b) 90-count bottle NDC 60429-737-90; Class IINov 10, 2023Failed Impurities/Degradation Specifications-Manufacturer Ap |
| PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90; b)1000-count bottle, NDC 60429-735-10; Class IINov 10, 2023Failed Impurities/Degradation Specifications-Manufacturer Ap |
| Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., ManufacturClass IIMay 25, 2023Lack of Assurance of Sterility: Tamper Evidence Seal is miss |
| Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Manufactured by Patheon Pharmaceuticals Inc., OH, Packaged by Class IIOct 6, 2022Failed impurities/degradation specifications: Finished produ |
| Rifampin Capsules, USP, 300 mg, packaged in a) 30-count bottle (NDC 51407-323-30), b) 60-count bottle (NDC 51407-323-60)Class IIOct 6, 2022Failed impurities/degradation specifications: Finished produ |
| Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, IncorpClass ISep 29, 2022Label Mix - up; a bottle labeled as Atenolol 25mg Tablets co |
| Enalapril Maleate Tablets, USP; 2.5 mg; 90 tablets, NDC 60429-183-90; manufactured by Taro Pharmaceutical Industries, LtClass IIMar 16, 2022CGMP Deviations |
| Enalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro Pharmaceutical Industries, LtdClass IIMar 16, 2022CGMP Deviations |
| Enalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro Pharmaceutical Industries, LtdClass IIMar 16, 2022CGMP Deviations |
| Enalapril Maleate Tablets, USP; 5 mg; 90 tablets, NDC 60429-184-90; manufactured by Taro Pharmaceutical Industries, Ltd.Class IIMar 16, 2022CGMP Deviations |
| Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSClass IIMar 2, 2022CGMP Deviation: Potential cross-contamination with other dru |
| Ezetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactured by Dr. Reddy's LaborClass IIOct 14, 2021Failed Excipient Specifications and Presence of Foreign Tabl |
| Ezetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufactured by Dr. Reddy's Laboratories LA Class IIOct 14, 2021Failed Excipient Specification; product manufactured using a |
| Omeprazole Delayed Release Capsules, USP, 20 mg, 1000-count bottles, Rx only, Packaged by GSMS Incorporated, Camarillo, Class IIMar 19, 2021Failed Impurities/Degradation Specifications: Out of Specifi |